A new treatment strategy for melanoma patients cuts the risk of the skin cancer recurring within five years nearly in half, researchers at New York’s NYU Langone Perlmutter Cancer Center said Monday.
Most recurrences of the deadliest form of skin cancer develop within the first 2-3 years after treatment, but melanoma can recur even over a decade later, according to the AIM at Melanoma Foundation.
